author-photo

Shirish M. Gadgeel

Henry Ford Health System

11

Papers

3

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

P10.03 Pembrolizumab With or Without Chemotherapy for Advanced Lung Cancer: A Real-World Analysis of Key Prognostic Factors

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Blood First Assay Screening Trial (BFAST) in Treatment-Naive Advanced or Metastatic NSCLC: Initial Results of the Phase 2 ALK-Positive Cohort.

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (1)
P08.04 Comparative Clinical Outcomes Between EGFR Exon20ins and Wildtype NSCLC Treated with Immune Checkpoint Inhibitors

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
The Global Impact of COVID-19 on Telehealth and Care for Persons With Thoracic Cancers

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Comparative Clinical Outcomes for Patients With Advanced NSCLC Harboring EGFR Exon 20 Insertion Mutations and Common EGFR Mutations

2021 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (0)
The real-word evidence of first-line treatment of pembrolizumab in advanced NSCLC.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
1281O Atezolizumab (atezo) vs platinum-based chemo in blood-based tumour mutational burden-positive (bTMB+) patients (pts) with first-line (1L) advanced/metastatic (m)NSCLC: Results of the Blood First Assay Screening Trial (BFAST) phase III cohort C

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Comparison of SP142 and 22C3 Immunohistochemistry PD-L1 Assays for Clinical Efficacy of Atezolizumab in Non-Small Cell Lung Cancer: Results From the Randomized OAK Trial.

2021 Clinical Lung Cancer
Show All
- Source
- Cite
- Save
Citations (1)